COMBINED MODALITY THERAPY WITH RADIATION, TEMOZOLOMIDE, AND PI3-KINASE INHIBITORS FOR THE POTENTIAL TREATMENT OF MALIGNANT GLIOMAS

被引：0
|
作者：
Prasad, Gautam [1 ]
Mueller, Sabine [1 ]
Yang, Xiaodong [1 ]
James, C. David [1 ]
Berger, Mitchel [1 ]
Prados, Michael [1 ]
Haas-Kogan, Daphne [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
NEURO-ONCOLOGY | 2008年 / 10卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：792 / 793
页数：2
相关论文
共 50 条
  • [21] CONTEMPORARY APPROACHES TO THE TREATMENT OF MALIGNANT GLIOMAS WITH RADIATION-THERAPY
    LEIBEL, SA
    SCOTT, CB
    LOEFFLER, JS
    SEMINARS IN ONCOLOGY, 1994, 21 (02) : 198 - 219
  • [22] A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas
    Kumthekar, Priya
    Grimm, Sean
    Chandler, James
    Mehta, Minesh
    Marymont, Maryanne
    Levy, Robert
    Muro, Kenji
    Helenowski, Irene
    McCarthy, Katie
    Fountas, Leanne
    Raizer, Jeffrey
    JOURNAL OF NEURO-ONCOLOGY, 2017, 133 (03) : 589 - 594
  • [23] Phase I study of arsenic trioxide and temozolomide in combination with radiation therapy in patients with malignant gliomas
    Grimm, Sean A.
    Marymont, Maryanne
    Chandler, James P.
    Muro, Kenji
    Newman, Steven B.
    Levy, Robert M.
    Jovanovic, Borko
    McCarthy, Katie
    Raizer, Jeffrey J.
    JOURNAL OF NEURO-ONCOLOGY, 2012, 110 (02) : 237 - 243
  • [24] A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas
    Priya Kumthekar
    Sean Grimm
    James Chandler
    Minesh Mehta
    Maryanne Marymont
    Robert Levy
    Kenji Muro
    Irene Helenowski
    Katie McCarthy
    Leanne Fountas
    Jeffrey Raizer
    Journal of Neuro-Oncology, 2017, 133 : 589 - 594
  • [25] PHASE II STUDY OF ARSENIC TRIOXIDE AND TEMOZOLOMIDE IN COMBINATION WITH RADIATION THERAPY IN PATIENTS WITH MALIGNANT GLIOMAS
    Kumthekar, P.
    Grimm, S. A.
    Marymont, M.
    Mehta, M.
    Chandler, J.
    Muro, K.
    Jovanovic, B.
    Helenowski, I.
    McCarthy, K.
    Raizer, J.
    NEURO-ONCOLOGY, 2014, 16
  • [26] Phase I study of arsenic trioxide and temozolomide in combination with radiation therapy in patients with malignant gliomas
    Sean A. Grimm
    Maryanne Marymont
    James P. Chandler
    Kenji Muro
    Steven B. Newman
    Robert M. Levy
    Borko Jovanovic
    Katie McCarthy
    Jeffrey J. Raizer
    Journal of Neuro-Oncology, 2012, 110 : 237 - 243
  • [27] Selective sensitisation of tumour cells to the induction of apoptosis with inhibitors of PI3-kinase and PKC
    O'Gorman, D
    McGahon, A
    Cotter, TG
    BRITISH JOURNAL OF CANCER, 1998, 78 : 35 - 35
  • [28] Discovery and Toxicological Profiling of Aminopyridines as Orally Bioavailable Selective Inhibitors of PI3-Kinase γ
    Bellenie, Benjamin R.
    Hall, Edward
    Bruce, Ian
    Spendiff, Matthew
    Culshaw, Andrew
    McDonald, Sarah
    Ambarkhane, Ameet
    Chinn, Colin
    Thomas, Matthew
    Rosner, Elisabeth
    Bracher, Marguerite
    Nicklin, Paul
    Marshall, Stephen
    Coote, Julie
    Cullen, Eva
    Tessier, Clemence
    Wuersch, Kuno
    Lal, Ajay
    Wallis, Gillian
    Hollingworth, Gregory J.
    Neef, James
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (16) : 12304 - 12321
  • [29] The role of PDGF receptor inhibitors and PI3-kinase signaling in the pathogenesis of corneal neovascularization
    Dell, Susanne
    Peters, Swaantje
    Muether, Philipp
    Kociok, Norbert
    Joussen, Antonia M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (05) : 1928 - 1937
  • [30] Radiation-induced upregulation of telomerase activity escapes PI3-kinase inhibition in two malignant glioma cell lines
    Millet, P.
    Granotier, C.
    Etienne, O.
    Boussin, F. D.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 43 (02) : 375 - 382
12345